Psychedelic Drug Treatments : : Assisting the Therapeutic Process / / Ben Sessa, Eileen Worthley.

Psychedelic Drug Treatments: Assisting the Therapeutic Process provides information about current and quite viable investigation into reviving and progressing with neurological research that began in the middle of the 20th century and was brought to a halt when certain drugs were banned in the 1970s...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Place / Publishing House:Dulles, VA : : Mercury Learning and Information, , [2016]
©2016
Year of Publication:2016
Language:English
Series:MyModernHealth FAQs
Online Access:
Physical Description:1 online resource (60 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05212nam a22006735i 4500
001 9781937585587
003 DE-B1597
005 20230808014301.0
006 m|||||o||d||||||||
007 cr || ||||||||
008 230808t20162016 fo d z eng d
020 |a 9781937585587 
035 |a (DE-B1597)653450 
040 |a DE-B1597  |b eng  |c DE-B1597  |e rda 
041 0 |a eng 
044 |a vau  |c US-VA 
050 4 |a RM324.8  |b .S47 2016eb 
072 7 |a MED023000  |2 bisacsh 
082 0 4 |a 615.7883  |2 23 
100 1 |a Sessa, Ben,   |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Psychedelic Drug Treatments :  |b Assisting the Therapeutic Process /  |c Ben Sessa, Eileen Worthley. 
264 1 |a Dulles, VA :   |b Mercury Learning and Information,   |c [2016] 
264 4 |c ©2016 
300 |a 1 online resource (60 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 0 |a MyModernHealth FAQs 
505 0 0 |t Frontmatter --   |t Contents --   |t Preface --   |t Acknowledgments --   |t PART ONE An Introduction to Psychotropic and Psychedelic Drugs --   |t An Introduction to Psychotropic and Psychedelic Drugs. Introduction --   |t CHAPTER 1 Psychoactive Compounds --   |t CHAPTER 2 Psychedelic Compounds --   |t CHAPTER 3 A Bit About the Brain --   |t CHAPTER 4 How Do Psychoactive Medications Work in the Brain? --   |t PART TWO A Brief History of Research Efforts --   |t A Brief History of Research Efforts. Introduction --   |t CHAPTER 5 A Brief History: From Ages Past to Research in the Early 20th Century --   |t CHAPTER 6 Psychedelic Research and Pioneers in the mid-1900s --   |t CHAPTER 7 Promising Research Grinds to a Halt --   |t PART THREE Current Research --   |t Current Research. Introduction --   |t CHAPTER 8 Making Pharmaceuticals Legally Available --   |t CHAPTER 9 Current Research --   |t CHAPTER 10 Cannabis --   |t PART FOUR The Future of Psychedelics --   |t The Future of Psychedelics. Introduction --   |t CHAPTER 11 The Future for Psychedelic-Assisted Psychotherapy --   |t CHAPTER 12 Safety Issues, Side Effects, and Ethics --   |t CHAPTER 13 Opening the Door to a Better Understanding --   |t Summary --   |t Appendix --   |t Index 
506 0 |a restricted access  |u http://purl.org/coar/access_right/c_16ec  |f online access with authorization  |2 star 
520 |a Psychedelic Drug Treatments: Assisting the Therapeutic Process provides information about current and quite viable investigation into reviving and progressing with neurological research that began in the middle of the 20th century and was brought to a halt when certain drugs were banned in the 1970s. Using a question/answer format, the book will introduce you to the way in which the chemical compounds known as psychedelics affect the brain, provide you with the definitions of key terms particular to the neurological and psychological vocabulary, describe the specific disorders that can realistically be helped or relieved through treatment with psychedelics, and offer information with regard to current research being conducted in the field. This text will discuss the history of the earlier research efforts and will examine the likelihood of a resurgence of interest in the successful development of methods and practices of clinical therapy assisted by psychedelic drugs. The purpose of this volume is to promote an understanding of the use of psychedelics as tools to assist therapy and to challenge the 40-year-old prejudices against research into the possible benefits of these drugs.Features:•Questions and answers about the history, research, and treatments related to psychedelic drugs •Makes a case for the re-evaluation of psychedelics — LSD, MDMA (‘ecstasy’), DMT, psilocybin, ayahuasca, peyote, ibogaine, and more — and their clinical potential for treating a range of conditions from post-traumatic stress disorder and depression to autism and cluster headaches.•Includes numerous in-text resources such as links to Web sites, videos, articles, blogs, etc. from NIH, FDA, YouTube, and university/clinical studies 
530 |a Issued also in print. 
538 |a Mode of access: Internet via World Wide Web. 
546 |a In English. 
588 0 |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 08. Aug 2023) 
650 0 |a Hallucinogenic drugs  |x History. 
650 0 |a Hallucinogenic drugs  |x Therapeutic use. 
650 4 |a Consumer Health. 
650 7 |a MEDICAL / Drug Guides.  |2 bisacsh 
700 1 |a Worthley, Eileen,   |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
776 0 |c EPUB  |z 9781937585594 
776 0 |c print  |z 9781936420445 
856 4 0 |u https://www.degruyter.com/isbn/9781937585587 
856 4 2 |3 Cover  |u https://www.degruyter.com/document/cover/isbn/9781937585587/original 
912 |a EBA_BACKALL 
912 |a EBA_CL_MDPM 
912 |a EBA_DGALL 
912 |a EBA_EBACKALL 
912 |a EBA_EBKALL 
912 |a EBA_ECL_MDPM 
912 |a EBA_EEBKALL 
912 |a EBA_ESTMALL 
912 |a EBA_STMALL 
912 |a GBV-deGruyter-alles 
912 |a PDA12STME 
912 |a PDA13ENGE 
912 |a PDA18STMEE 
912 |a PDA5EBK